(Q45250978)

English

Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study

scientific article published on 7 June 2010

In more languages
default for all languages
No label defined

No description defined

Statements

Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study (English)
European Lung Cancer Working Party (ELCWP)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit